I. Gorman

发表

Investigation of the mechanisms mediating MDMA “Ecstasy”-induced increases in cerebro-cortical perfusion determined by btASL MRI

P. Duffy, C. Kerskens, M. Kelly, 2015, Psychopharmacology.

Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats

J. Horáček, V. Bubeníková-Valešová, M. Balíková, 2012, Psychopharmacology.

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice

Elizabeth M. Nielson, I. Gorman, Aja Molinar, 2021, Frontiers in Psychology.

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer M. Mitchell, Julie B. Wang, R. Amiaz, 2021, Nature Medicine.

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder

L. Jerome, A. Feduccia, B. Yazar-Klosinski, 2020, Journal of traumatic stress.

Electroencephalographic Spectral and Coherence Analysis of Ketamine in Rats: Correlation with Behavioral Effects and Pharmacokinetics

Marie Balíková, Cyril Höschl, Jiří Horáček, 2011, Neuropsychobiology.

The effect of ((−)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis

Jiří Horáček, Tomáš Páleníček, Martin Brunovský, 2014, Pharmacology Biochemistry and Behavior.

Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats

Petr Zach, Marie Balíková, Cyril Höschl, 2012, Psychopharmacology.

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

Jennifer M. Mitchell, Julie B. Wang, R. Amiaz, 2023, Focus.

Neuropathology of Drug Addictions and Substance Misuse

P. Winkler, R. Kočárová, I. Gorman, 2016 .